This module uses fundamental data of Sotera Health to approximate its Piotroski F score. Sotera Health F Score is determined by combining nine binary scores representing 3 distinct fundamental categories of Sotera Health Co. These three categories are profitability, efficiency, and funding. Some research analysts and sophisticated value traders use Piotroski F Score to find opportunities outside of the conventional market and financial statement analysis.They believe that some of the new information about Sotera Health financial position does not get reflected in the current market share price suggesting a possibility of arbitrage. Check out Sotera Health Altman Z Score, Sotera Health Correlation, Sotera Health Valuation, as well as analyze Sotera Health Alpha and Beta and Sotera Health Hype Analysis.
Sotera
Piotroski F Score
Price To Sales Ratio
Ptb Ratio
Days Sales Outstanding
Book Value Per Share
Free Cash Flow Yield
Operating Cash Flow Per Share
Stock Based Compensation To Revenue
Capex To Depreciation
Pb Ratio
Ev To Sales
Free Cash Flow Per Share
Roic
Inventory Turnover
Net Income Per Share
Days Of Inventory On Hand
Payables Turnover
Capex To Revenue
Cash Per Share
Pocfratio
Interest Coverage
Capex To Operating Cash Flow
Pfcf Ratio
Days Payables Outstanding
Income Quality
Roe
Ev To Operating Cash Flow
Pe Ratio
Return On Tangible Assets
Ev To Free Cash Flow
Earnings Yield
Intangibles To Total Assets
Net Debt To E B I T D A
Current Ratio
Tangible Book Value Per Share
Receivables Turnover
Graham Number
Shareholders Equity Per Share
Debt To Equity
Capex Per Share
Graham Net Net
Revenue Per Share
Interest Debt Per Share
Debt To Assets
Enterprise Value Over E B I T D A
Short Term Coverage Ratios
Price Earnings Ratio
Operating Cycle
Price Book Value Ratio
Price Earnings To Growth Ratio
Days Of Payables Outstanding
Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio
Pretax Profit Margin
Ebt Per Ebit
Operating Profit Margin
Effective Tax Rate
Company Equity Multiplier
Long Term Debt To Capitalization
Total Debt To Capitalization
Return On Capital Employed
Debt Equity Ratio
Ebit Per Revenue
Quick Ratio
Dividend Paid And Capex Coverage Ratio
Net Income Per E B T
Cash Ratio
Cash Conversion Cycle
Operating Cash Flow Sales Ratio
Days Of Inventory Outstanding
Days Of Sales Outstanding
Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios
Price To Book Ratio
Fixed Asset Turnover
Capital Expenditure Coverage Ratio
Price Cash Flow Ratio
Enterprise Value Multiple
Debt Ratio
Cash Flow To Debt Ratio
Price Sales Ratio
Return On Assets
Asset Turnover
Net Profit Margin
Gross Profit Margin
Price Fair Value
Return On Equity
Net Borrowings
Total Cashflows From Investing Activities
Other Cashflows From Financing Activities
Capital Expenditures
Total Cash From Operating Activities
Change To Operating Activities
Other Cashflows From Investing Activities
Change To Netincome
Change To Liabilities
Change To Inventory
Investments
Change In Cash
Depreciation
Change To Account Receivables
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Stock Based Compensation
Free Cash Flow
Change In Working Capital
Begin Period Cash Flow
Other Non Cash Items
Sale Purchase Of Stock
Other Current Liab
Total Current Liabilities
Other Liab
Net Tangible Assets
Retained Earnings
Accounts Payable
Other Assets
Net Receivables
Other Current Assets
Other Stockholder Equity
Total Current Assets
Common Stock
Property Plant Equipment
Total Assets
Short Long Term Debt Total
Total Stockholder Equity
Property Plant And Equipment Net
Current Deferred Revenue
Net Debt
Cash
Non Current Assets Total
Non Currrent Assets Other
Long Term Debt
Cash And Short Term Investments
Good Will
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Capital Lease Obligations
Inventory
Total Liab
Net Invested Capital
Property Plant And Equipment Gross
Short Long Term Debt
Accumulated Other Comprehensive Income
Non Current Liabilities Other
Net Working Capital
Short Term Debt
Intangible Assets
Short Term Investments
Interest Expense
Net Income Applicable To Common Shares
Income Tax Expense
Minority Interest
Ebit
Tax Provision
Net Interest Income
Depreciation And Amortization
Selling General Administrative
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Net Income From Continuing Ops
Ebitda
Cost Of Revenue
Total Operating Expenses
Reconciled Depreciation
Income Before Tax
Total Other Income Expense Net
Probability Of Bankruptcy
At present, Sotera Health's Net Debt To EBITDA is projected to decrease significantly based on the last few years of reporting. The current year's Interest Debt Per Share is expected to grow to 9.09, whereas Short and Long Term Debt Total is forecasted to decline to about 1.7 B. At present, Sotera Health's Days Sales Outstanding is projected to decrease significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 1.66, whereas PTB Ratio is forecasted to decline to 10.14.
At this time, it appears that Sotera Health's Piotroski F Score is Frail. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
The critical factor to consider when applying the Piotroski F Score to Sotera Health is to make sure Sotera is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Sotera Health's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Sotera Health's financial numbers are properly reported.
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Sotera Health's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Sotera Health in a much-optimized way.
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.
Common Stock Shares Outstanding
303.7 Million
At present, Sotera Health's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting.
Sotera Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Sotera Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Sotera Health's managers, analysts, and investors.
Environmental
Governance
Social
About Sotera Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sotera Health Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sotera Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sotera Health Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Sotera Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Sotera Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Sotera Health Co Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Sotera Health Co Stock:
You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sotera Health. If investors know Sotera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sotera Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.62)
Earnings Share
0.25
Revenue Per Share
3.969
Quarterly Revenue Growth
0.085
Return On Assets
0.0768
The market value of Sotera Health is measured differently than its book value, which is the value of Sotera that is recorded on the company's balance sheet. Investors also form their own opinion of Sotera Health's value that differs from its market value or its book value, called intrinsic value, which is Sotera Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sotera Health's market value can be influenced by many factors that don't directly affect Sotera Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sotera Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sotera Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sotera Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.